Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT01519323
Title BRIM-P
Recruitment Terminated
Gender both
Phase Phase I
Variant Requirements Yes
Sponsors Hoffmann-La Roche
Indications

melanoma

Therapies

Vemurafenib

Age Groups: child
Covered Countries USA

Additional content available in CKB BOOST